🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/12/2020 85,35 85,78 79,75 79,94 -5,05% 7,07% 856.600
24/12/2020 84,92 86,75 83,62 84,19 -1,38% 3,69% 313.100
23/12/2020 82,83 86,11 81,74 85,37 +3,07% 5,28% 735.700
22/12/2020 82,67 83,90 80,82 82,83 +0,98% 3,73% 1.037.500
21/12/2020 77,03 82,06 74,62 82,03 +2,33% 9,66% 1.441.800
18/12/2020 79,97 82,06 79,05 80,16 +1,00% 3,76% 2.977.900
17/12/2020 76,96 79,70 76,89 79,37 +2,24% 3,65% 873.900
16/12/2020 76,92 77,96 74,95 77,63 +1,54% 3,91% 842.500
15/12/2020 75,75 77,20 74,81 76,45 +2,06% 3,15% 887.500
14/12/2020 74,68 78,27 74,68 74,91 +1,15% 4,81% 1.186.200
11/12/2020 73,64 75,03 72,66 74,06 +0,07% 3,22% 1.008.000
10/12/2020 68,49 74,11 68,14 74,01 +7,41% 8,72% 1.395.100
09/12/2020 68,66 72,17 67,98 68,90 +1,06% 6,11% 1.455.600
08/12/2020 66,17 68,34 65,70 68,18 +3,54% 3,99% 702.500
07/12/2020 65,20 66,72 64,35 65,85 +0,86% 3,63% 793.500
04/12/2020 63,93 65,57 63,03 65,29 +2,05% 3,97% 715.200
03/12/2020 64,43 65,00 63,50 63,98 -1,14% 2,33% 514.900
02/12/2020 62,03 65,00 61,21 64,72 +3,32% 6,11% 878.200
01/12/2020 63,34 63,94 61,96 62,64 +0,18% 3,13% 758.400
30/11/2020 63,25 65,62 61,92 62,53 -0,73% 5,85% 1.512.300
27/11/2020 57,01 63,00 56,95 62,99 +10,47% 10,62% 1.023.700
25/11/2020 60,17 60,17 56,05 57,02 -5,58% 6,85% 1.952.500
24/11/2020 65,50 66,75 58,02 60,39 -11,45% 13,33% 3.536.000
23/11/2020 68,26 69,56 66,56 68,20 -0,87% 4,40% 1.101.600
20/11/2020 68,07 69,30 66,85 68,80 -0,17% 3,59% 719.900
19/11/2020 69,64 72,50 68,38 68,92 +0,82% 5,92% 1.178.500
18/11/2020 70,96 72,48 67,63 68,36 -3,43% 6,83% 1.099.300
17/11/2020 68,46 71,45 67,64 70,79 +2,49% 5,57% 1.043.300
16/11/2020 70,00 70,90 67,40 69,07 +0,77% 5,00% 779.900
13/11/2020 70,08 70,98 68,43 68,54 -1,00% 3,64% 822.400